Neon Parody Labs – GENOMIRATHEON™ Licensing Launch (September 2025)

GENOMIRATHEON™ is the first treaty-filed DNA licensing rail developed by Neon Parody Labs.Filed under the Budapest Treaty, GENOMIRATHEON™ transforms gene expression into legally recognized, auditable intellectual property. Each validator-confirmed gene expression event (fluorescence λ 662–664 nm; electrochemical pulses +2.6–2.8 mV) generates an enforceable licensing record. The September 2025 launch introduced a limited issuance of 461 licenses worldwide (314 academic, 111 industrial, 33 sovereign, 3 public-benefit). Early coverage was published via Associated Press, Yahoo Finance, and MarketWatch, and syndication reports showed global readership across the US, EU, China, Norway, and Ireland. This archive preserves the official distribution reports, licensing framework, and validator signal diagrams that demonstrate how biological events can now carry legal and financial weight.